Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration (Q37029655)
Jump to navigation
Jump to search
scientific article published on May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration |
scientific article published on May 2011 |
Statements
1 reference
Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration (English)
1 reference
Daniel H Geschwind
1 reference
Sama F Sleiman
1 reference
Brett C Langley
1 reference
Manuela Basso
1 reference
Jill Berlin
1 reference
Li Xia
1 reference
Jimmy B Payappilly
1 reference
Madan K Kharel
1 reference
Hengchang Guo
1 reference
J Lawrence Marsh
1 reference
Leslie Michels Thompson
1 reference
Lata Mahishi
1 reference
Preeti Ahuja
1 reference
W Robb MacLellan
1 reference
Giovanni Coppola
1 reference
Jürgen Rohr
1 reference
Rajiv R Ratan
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference